A new drug is being proposed for the treatment of migraine headaches.Unfortunately, some users in early tests of the drug have reported mild nausea as a side effect. The FDA will reject the drug if it thinks that more than 15% (i.e. 0.15) of the population would suffer from this side effect. In an experiment to test this side effect, 400 people who suffer from migraine headaches receive the new drug and 80 of them report nausea as a side effect.Carry out a hypothesis test to determine if the FDA should reject the drug.Use 5% significance level.